New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
New program shows promise in reducing financial burden of cancer care

New program shows promise in reducing financial burden of cancer care

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainThe rising cost of cancer care puts patients and their caregivers at increased risk of experiencing financial toxicity,
World medicine December 04,2023
New program shows promise in reducing financial burden of cancer care

New program shows promise in reducing financial burden of cancer care

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainThe rising cost of cancer care puts patients and their caregivers at increased risk of experiencing financial toxicity,
World medicine December 04,2023
Pathogenic genetic variations found to boost the risk of H. pylori–related stomach cancer

Pathogenic genetic variations found to boost the risk of H. pylori–related stomach cancer

byRIKENPathogenic Variant and H. pylori Infection on Gastric Cancer Risk. Credit: RIKENA large case-control study by international researchers at the RIKEN Center for Integrative Medical Science
World medicine December 04,2023
Pathogenic genetic variations found to boost the risk of H. pylori–related stomach cancer

Pathogenic genetic variations found to boost the risk of H. pylori–related stomach cancer

byRIKENPathogenic Variant and H. pylori Infection on Gastric Cancer Risk. Credit: RIKENA large case-control study by international researchers at the RIKEN Center for Integrative Medical Science
World medicine December 04,2023
'Search and destroy' treatment found to improve quality of life for patients with advanced prostate cancer

'Search and destroy' treatment found to improve quality of life for patients with advanced prostate cancer

byInstitute of Cancer ResearchProstate cancer cell. Credit: Anne Weston, Francis Crick Institute.A new radioactive medicine that seeks out tumor cells to deliver a targeted dose of radiation gre
World medicine December 04,2023
'Search and destroy' treatment found to improve quality of life for patients with advanced prostate cancer

'Search and destroy' treatment found to improve quality of life for patients with advanced prostate cancer

byInstitute of Cancer ResearchProstate cancer cell. Credit: Anne Weston, Francis Crick Institute.A new radioactive medicine that seeks out tumor cells to deliver a targeted dose of radiation gre
World medicine December 04,2023
Predicting neuroblastoma outcomes with molecular evolution

Predicting neuroblastoma outcomes with molecular evolution

by Justin Jackson , Medical XpressEarly genomic instability is associated with unfavorable outcome. a, Enrichment of chromosomal aberrations and clinical parameters in early- and late-MRCA tumors pred
World medicine December 04,2023
Predicting neuroblastoma outcomes with molecular evolution

Predicting neuroblastoma outcomes with molecular evolution

by Justin Jackson , Medical XpressEarly genomic instability is associated with unfavorable outcome. a, Enrichment of chromosomal aberrations and clinical parameters in early- and late-MRCA tumors pred
World medicine December 04,2023
Study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis

Study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis

byNational Cancer InstituteLYG scans. Credit: National Cancer InstituteResults from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low
World medicine December 04,2023
Study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis

Study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis

byNational Cancer InstituteLYG scans. Credit: National Cancer InstituteResults from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low
World medicine December 04,2023
A promising strategy to combat tumor cells by targeting combination of cellular mechanisms

A promising strategy to combat tumor cells by targeting combination of cellular mechanisms

byUniversity of SaskatchewanEPHA2, c-MET and EGFR levels in human tumors. (A) RNA-Seq Expectation Maximization (RSEM) normalized expression levels in the log2 scale for EGFR, c-MET and EPHA2 in
World medicine December 04,2023
A promising strategy to combat tumor cells by targeting combination of cellular mechanisms

A promising strategy to combat tumor cells by targeting combination of cellular mechanisms

byUniversity of SaskatchewanEPHA2, c-MET and EGFR levels in human tumors. (A) RNA-Seq Expectation Maximization (RSEM) normalized expression levels in the log2 scale for EGFR, c-MET and EPHA2 in
World medicine December 04,2023
Judge's decision would make some no-cost cancer screenings a thing of the past

Judge's decision would make some no-cost cancer screenings a thing of the past

by Julie Appleby, Michelle AndrewsCredit: CC0 Public DomainA federal judge on Thursday overturned a portion of the Affordable Care Act that makes preventive services, such as some cancer screenings, f
World medicine December 04,2023
Judge's decision would make some no-cost cancer screenings a thing of the past

Judge's decision would make some no-cost cancer screenings a thing of the past

by Julie Appleby, Michelle AndrewsCredit: CC0 Public DomainA federal judge on Thursday overturned a portion of the Affordable Care Act that makes preventive services, such as some cancer screenings, f
World medicine December 04,2023
Interview with Hair Transplant Surgeon Dr. B Limmer

Interview with Hair Transplant Surgeon Dr. B Limmer

 by Kevin RandsDr. Bobby Limmer speaks to HairlossTalk on Dr. Woods, ISHRS Conference, and Follicular Unit TransplantationWorld renowned hair transplant surgeon Dr. Bobby Limme
Dermatology December 04,2023
Interview with Hair Transplant Surgeon Dr. B Limmer

Interview with Hair Transplant Surgeon Dr. B Limmer

 by Kevin RandsDr. Bobby Limmer speaks to HairlossTalk on Dr. Woods, ISHRS Conference, and Follicular Unit TransplantationWorld renowned hair transplant surgeon Dr. Bobby Limme
Dermatology December 04,2023
Researchers discover two-pronged approach to stimulate STING antitumor activity

Researchers discover two-pronged approach to stimulate STING antitumor activity

byH. Lee Moffitt Cancer Center & Research InstituteSchematic of the STING agonist treatment schedule. Groups of STINGgt/gtmice were injected subcutaneously with 1.5 × 105B16-ISG
World medicine December 04,2023
Researchers discover two-pronged approach to stimulate STING antitumor activity

Researchers discover two-pronged approach to stimulate STING antitumor activity

byH. Lee Moffitt Cancer Center & Research InstituteSchematic of the STING agonist treatment schedule. Groups of STINGgt/gtmice were injected subcutaneously with 1.5 × 105B16-ISG
World medicine December 04,2023
'You (might) have cancer': Study investigates ways to improve communication between doctors and patients

'You (might) have cancer': Study investigates ways to improve communication between doctors and patients

byLudwig Maximilian University of MunichBayesian tree vs. diagnostic tree. The statistical information displayed corresponds to the Bayesian information vs. diagnostic information presented in T
World medicine December 04,2023
'You (might) have cancer': Study investigates ways to improve communication between doctors and patients

'You (might) have cancer': Study investigates ways to improve communication between doctors and patients

byLudwig Maximilian University of MunichBayesian tree vs. diagnostic tree. The statistical information displayed corresponds to the Bayesian information vs. diagnostic information presented in T
World medicine December 04,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com